Works matching IS 22969403 AND DT 2023 AND VI 8 AND IP 1
Results: 5
Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 1, p. 1, doi. 10.1159/000530825
- By:
- Publication type:
- Article
Smoking Is Not an Independent Risk Factor for Surgery in Patients with Crohn's Disease on Biologic Therapy.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 1, p. 1, doi. 10.1159/000530689
- By:
- Publication type:
- Article
Construction of an Explanatory Model for Quality of Life in Outpatients with Ulcerative Colitis.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 1, p. 1, doi. 10.1159/000530455
- By:
- Publication type:
- Article
Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 1, p. 1, doi. 10.1159/000530139
- By:
- Publication type:
- Article
A Systematic Review of Self-Management Interventions for Patients with Inflammatory Bowel Disease.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 1, p. 1, doi. 10.1159/000530021
- By:
- Publication type:
- Article